CSF1R and neoplasm: Whereas the M-CSFR inhibitors GW2580 or PLX3397 on their own were reported to have little effect on tumor growth in murine prostate cancer models, when added to radiotherapy, the M-CSFR inhibitors suppressed tumor growth more effectively than radiation alone (116).